4//SEC Filing
Aftab Blake 4
Accession 0001209191-23-046101
CIK 0001720580other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 6:10 PM ET
Size
28.4 KB
Accession
0001209191-23-046101
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Aftab Blake
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-14+50,000→ 50,000 totalExercise: $2.14Exp: 2031-04-29→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-14−56,612→ 0 totalExercise: $7.38Exp: 2031-10-11→ Common Stock (56,612 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-14−125,000→ 0 totalExercise: $15.52Exp: 2032-01-06→ Common Stock (125,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-14+60,000→ 60,000 totalExercise: $2.14Exp: 2032-05-09→ Common Stock (60,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-14+117,200→ 117,200 totalExercise: $2.14Exp: 2033-01-23→ Common Stock (117,200 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-14−50,000→ 0 totalExercise: $15.93Exp: 2031-04-29→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-14+56,612→ 56,612 totalExercise: $2.14Exp: 2031-10-11→ Common Stock (56,612 underlying) - Award
Stock Option (Right to Buy)
2023-08-14+125,000→ 125,000 totalExercise: $2.14Exp: 2032-01-06→ Common Stock (125,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-14−60,000→ 0 totalExercise: $12.18Exp: 2032-05-09→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-14−117,200→ 0 totalExercise: $9.05Exp: 2033-01-23→ Common Stock (117,200 underlying)
Footnotes (7)
- [F1]On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 14, 2023 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
- [F2]A total of 60,000 shares subject to an employee stock option were granted to the Reporting Person on October 12, 2021, with 25% of the shares subject to this option vested and exercisable on April 5, 2022, and the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. The Reporting Person previously exercised 3,388 shares subject to this option.
- [F3]The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.
- [F4]25% of the shares subject to this option vested and became exercisable on October 12, 2022, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
- [F5]25% of the shares subject to this option vested and became exercisable on January 7, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
- [F6]25% of the shares subject to this option vested and became exercisable on April 29, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
- [F7]The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 24, 2023, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
Documents
Issuer
Adicet Bio, Inc.
CIK 0001720580
Entity typeother
Related Parties
1- filerCIK 0001886986
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 6:10 PM ET
- Size
- 28.4 KB